A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM
Dr Vania Hungria speaks to ecancer about managing multiple myeloma during the COVID-19 pandemic.
She says that, although the pandemic has caused setbacks in cancer care, there are ways to overcome them. She talks first about the problems faced in Brazil post-pandemic and then talks about the general rules that must be followed to overcome some of these problems.
In the end she says she hopes the “new normal” would soon go back to the “old normal” and that doctors must not stop treatment just because of this pandemic. Cancer patients need immediate treatment and care and it cannot be stopped.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.
A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM
Supporting breast cancer patients in Vietnam
Nigeria solidarity support fund and the annual youth engagement campaign on HPV
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Neo-adjuvant therapy for different cancers in the Philippines
Lung cancer screening and treatment in the Philippines
Choosing Wisely to mitigate financial toxicity in cancer care in Africa
Haemopathy burden in the National Cancer Center of Cambodia
Decision making in paediatric oncology